Joff Masukawa
Board Member
LinkedIn | Website
Joff Masukawa is President and founder of Diligentia Strategy, a life-sciences consultancy founded in 2015 that develops commercialization strategies for manufacturers of rare orphan and specialty drugs, cell and gene therapies, and other novel emerging medical innovations. Diligentia also offers federal and state government relations and public affairs strategy and services to facilitate client engagement with policymakers and government agencies in support of business objectives. Prior to founding Diligentia, Joff was Vice President and Global Head of Government Relations and Public Affairs at Shire, where he designed and led strategies to build the company’s brand, engagement and leadership with government representatives and agencies, patient advocacy groups, payors, industry associations and other key external stakeholders. Joff has held senior level leadership roles spanning commercial and corporate functions, including market access, government and public affairs, patient and provider services, and sales and marketing at Shire, Genzyme, Visible Genetics, Gentiva and Labcorp. He has developed and executed numerous commercial launch strategies for first-in-class products and is an expert at developing and aligning optimal legislative, regulatory and market access solutions to support business objectives. He began his career as a clinical sales representative for Merck. He serves on the boards of Phoenicis Therapeutics, Caregiver Action Network, and the Center for Healthcare Innovation. Joff is also an advisor to America’s Health Foundation and a member of the American Society of Gene and Cell Therapy and the Innovation and Value Initiative. A first-generation American, Joff is a passionate advocate of diversity and inclusion in life sciences. He regularly collaborates across the industry, NGOs, and his personal network to convene important conversations and forums to advance the cause of older adults, racial and ethnic minorities, and the LGTBQ+ community to help them achieve their full potential. He holds a BA in international studies from Johns Hopkins University and completed his graduate studies in international affairs at the Johns Hopkins School of International Studies and in strategic communications at Columbia University.